X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (634) 634
index medicus (458) 458
pharmacology & pharmacy (430) 430
echinocandins (410) 410
antifungal agents - therapeutic use (398) 398
pharmacokinetics (343) 343
antifungal agents - pharmacokinetics (336) 336
caspofungin (285) 285
microbiology (282) 282
lipopeptides (268) 268
micafungin (262) 262
male (257) 257
antifungal agents - pharmacology (250) 250
female (242) 242
echinocandins - pharmacokinetics (236) 236
animals (235) 235
echinocandins - therapeutic use (233) 233
candidiasis - drug therapy (218) 218
antifungal agents - administration & dosage (204) 204
echinocandin (186) 186
infectious diseases (184) 184
amphotericin-b (179) 179
fluconazole (166) 166
echinocandins - administration & dosage (162) 162
anidulafungin (160) 160
echinocandins - pharmacology (159) 159
candidiasis (157) 157
antifungal agents (156) 156
antifungal agents - adverse effects (154) 154
mycoses - drug therapy (154) 154
voriconazole (149) 149
liposomal amphotericin-b (148) 148
adult (145) 145
microbial sensitivity tests (135) 135
invasive candidiasis (130) 130
middle aged (130) 130
aspergillosis - drug therapy (125) 125
pharmacology (117) 117
fungal-infections (113) 113
echinocandins - adverse effects (112) 112
mycoses (112) 112
aspergillosis (109) 109
lipopeptides - pharmacokinetics (103) 103
candida - drug effects (99) 99
safety (99) 99
treatment outcome (99) 99
peptides, cyclic - therapeutic use (97) 97
bacterial infections and mycoses (96) 96
aged (95) 95
amphotericin b (94) 94
child (93) 93
candida (91) 91
candidiasis - microbiology (90) 90
drug interactions (90) 90
lipopeptides - therapeutic use (88) 88
mice (86) 86
antifungal (83) 83
drug therapy, combination (83) 83
triazoles - therapeutic use (83) 83
in-vitro (82) 82
amphotericin b - therapeutic use (81) 81
drug therapy (81) 81
candidemia (80) 80
dose-response relationship, drug (80) 80
invasive fungal-infections (79) 79
pharmacodynamics (79) 79
adolescent (78) 78
lipopeptides - administration & dosage (77) 77
double-blind (76) 76
efficacy (74) 74
peptides, cyclic - pharmacokinetics (74) 74
therapy (73) 73
in-vitro activity (72) 72
invasive aspergillosis (71) 71
fungal infections (69) 69
pediatrics (69) 69
antifungal therapy (68) 68
infections (68) 68
mycology (67) 67
disease models, animal (66) 66
drug resistance, fungal (66) 66
health aspects (66) 66
antifungal agents - blood (65) 65
infant, newborn (64) 64
area under curve (62) 62
aspergillus (62) 62
immunology (61) 61
candida albicans - drug effects (59) 59
research (59) 59
epidemiology (56) 56
infant (56) 56
clinical trials as topic (55) 55
antifungals (54) 54
pulmonary aspergillosis (54) 54
candida-albicans (53) 53
child, preschool (53) 53
lipopeptides - adverse effects (53) 53
susceptibility (53) 53
candidiasis, invasive - drug therapy (52) 52
dosage and administration (52) 52
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (832) 832
Spanish (36) 36
German (10) 10
French (9) 9
Japanese (5) 5
Estonian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Pharmacokinetics, ISSN 0312-5963, 2016, Volume 55, Issue 10, pp. 1289 - 1294
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 1/2008, Volume 197, Issue 1, pp. 163 - 171
Journal Article
Critical Care, ISSN 1364-8535, 12/2015, Volume 19, Issue 1, p. 437
Introduction: Ex vivo experiments in extracorporeal membrane oxygenation (ECMO) circuits have identified octanol-water partition coefficient (logP, a marker of... 
ECMO | SEQUESTRATION | MATCHED COHORT | DRUG-THERAPY | LIFE-SUPPORT | VENTILATION | DISEASE | ADULTS | PROTEIN-BINDING | CIRCUIT | CRITICAL CARE MEDICINE | Echinocandins - chemistry | Fluconazole - chemistry | Echinocandins - pharmacokinetics | Thienamycins - pharmacokinetics | Ceftriaxone - chemistry | Carbapenems - pharmacokinetics | Sheep, Domestic - metabolism | Thienamycins - chemistry | Vancomycin - chemistry | Carbapenems - chemistry | Anti-Infective Agents - chemistry | Extracorporeal Membrane Oxygenation - utilization | Gentamicins - chemistry | Models, Theoretical | Sheep, Domestic - physiology | Ciprofloxacin - pharmacokinetics | Gentamicins - pharmacokinetics | Ceftriaxone - pharmacokinetics | Fluconazole - pharmacokinetics | Animals | Extracorporeal Membrane Oxygenation - mortality | Vancomycin - pharmacokinetics | Anti-Infective Agents - pharmacokinetics | Ciprofloxacin - chemistry | Critical Illness - therapy | Sheep | Lipopeptides | Acute respiratory distress syndrome | Usage | Antibiotics | Fluconazole | Analysis | Research | Ciprofloxacin | Chromatography | Blood proteins | Protein binding | Respiratory therapy | Ventilators | Medical research | Intensive care | Patients | Proteins | Scholarships & fellowships | Respiratory distress syndrome | Hernias | Sepsis | Renal replacement therapy | Drug therapy | Drug dosages
Journal Article
Critical Care Medicine, ISSN 0090-3493, 03/2011, Volume 39, Issue 3, pp. 560 - 570
OBJECTIVE:To address issues of antibiotic dosing during sustained low-efficiency dialysis by using available pharmacokinetic data, intermittent and continuous... 
dialysis | continuous renal replacement therapy | critical care | pharmacokinetics | sustained low-efficiency dialysis | anti-infectives | antibiotics | ACUTE KIDNEY INJURY | SLEDD-F | INTERMITTENT HEMODIALYSIS | SEPTIC PATIENTS | UREA KINETICS | HIGH-FLUX HEMODIALYSIS | EXTENDED DAILY DIALYSIS | INTENSIVE-CARE-UNIT | DAILY DIAFILTRATION | RENAL REPLACEMENT THERAPY | CRITICAL CARE MEDICINE | Critical Care - methods | Linezolid | Carbapenems - administration & dosage | Echinocandins - pharmacokinetics | Humans | Renal Dialysis - methods | Carbapenems - pharmacokinetics | Oxazolidinones - administration & dosage | Fluoroquinolones - pharmacokinetics | Peritoneal Dialysis, Continuous Ambulatory - adverse effects | Echinocandins - administration & dosage | Aminoglycosides - administration & dosage | Fluoroquinolones - administration & dosage | Vancomycin - administration & dosage | Acetamides - pharmacokinetics | Aminoglycosides - pharmacokinetics | Oxazolidinones - pharmacokinetics | Peritoneal Dialysis, Continuous Ambulatory - methods | Renal Insufficiency - therapy | Vancomycin - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Renal Dialysis - adverse effects | Daptomycin - pharmacokinetics | Anti-Bacterial Agents - administration & dosage | Daptomycin - administration & dosage | Acetamides - administration & dosage
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 07/2018, Volume 62, Issue 7
In 2025, approximately one out of five adults will be obese. Physiological changes associated with obesity have been shown to influence the pharmacokinetics of... 
Echinocandin | Antifungal therapy | Obese | Anidulafungin | Modeling | antifungal therapy | anidulafungin | modeling | echinocandin | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | obese
Journal Article